Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Fixed-Dose Combination Amlodipine Besylate 10 mg + Olmesartan Medoxomil 40 mg Tablets in Healthy Thai Subjects Under Fasting Conditions
TCTR20260126004Phase 1Not yet recruiting
- Sponsor
- Assoc. Prof. Somruedee Chatsiricharoenkul
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of amlodipine and olmesartan in hypertension (HTN) (2 arms), sponsored by Assoc. Prof. Somruedee Chatsiricharoenkul. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
amlodipineolmesartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on TCTR20260126004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260126004.